We are live on
!
Find out more
KK
Kotler Kevin Portfolio holdings
AUM
$427M
This Fund
S&P 500
This Quarter
Est. Return
+61.7%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$427M
AUM Growth
–
Cap. Flow
+$405M
Cap. Flow
% of AUM
94.72%
Top 10 Holdings %
Top 10 Hldgs %
89.56%
Holding
38
New
38
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AngioDynamics
ANGO
|
+$21.2M |
| 2 |
Aurinia Pharmaceuticals
AUPH
|
+$17.4M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$14.4M |
| 4 |
Neuropace
NPCE
|
+$8.44M |
| 5 |
Omeros
OMER
|
+$7.8M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.66% |
| 2 | Industrials | 1.36% |
| 3 | Consumer Discretionary | 0.53% |
| 4 | Financials | 0.06% |
Similar funds
STS
MCP
JHCM
MG
AWIRL
PPL
VW
DP
Kotler Kevin's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Kotler Kevin, which disclosed 38 positions worth $427M. Its ten largest holdings account for 90% of the portfolio.
Its largest position is AngioDynamics: 1,713,789 shares worth $22M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, followed by Industrials and Consumer Discretionary.
- Kotler Kevin's largest Q4 2025 buy was AngioDynamics: 1,713,789 shares worth $22M.
- Kotler Kevin's ten largest holdings make up 90% of its $427M portfolio in Q4 2025.
- Kotler Kevin disclosed 38 positions in Q4 2025, its first 13F filing on record.
Based on Kotler Kevin's 13F filing for Q4 2025, filed 17 Feb 2026.